Form 4: Director Michele Leonhart Equity Update for 908 Devices
Statement of Changes in Beneficial Ownership
Director Michele Leonhart acquired 14,083 shares of 908 Devices Inc. through RSU vesting and received new equity grants.
Summary
- Director Michele Leonhart exercised 14,083 Restricted Stock Units (RSUs) which vested on June 10, 2026.
- Following the exercise, the director was granted 13,656 new RSUs and 6,209 stock options on June 11, 2026.
- The new stock options have an exercise price of $8.22 and expire on June 10, 2036.
- The director's total beneficial ownership of common stock stands at 20,568 shares following these transactions.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard director compensation and equity maintenance.
Positives
- Director maintains a long-term alignment with company performance through continued equity participation.
- Equity grants are subject to future service-based vesting, incentivizing retention.
Negatives
- None noted; this is a standard director compensation and equity maintenance filing.
Risks
- Future vesting of equity is contingent upon the director's continued service to the company.
Future Outlook
The director's equity grants are subject to monthly vesting over 12 months for options and annual vesting for RSUs, contingent on continued service.
Management Comments
- The transactions were executed in accordance with standard director compensation plans.
Industry Context
StockSavvy.ai notes that director equity grants are standard practice for public companies to ensure board alignment with shareholder interests, particularly in the life sciences and instrumentation sector.
Comparison to Industry Standards
- The equity grant structure is consistent with standard corporate governance practices for NASDAQ-listed technology companies.
- Vesting schedules align with typical industry benchmarks for non-employee director compensation.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Director granted Power of Attorney to company officers for SEC filing purposes. | 01/08/2026 | Standard administrative procedure to ensure timely regulatory compliance. |
Stakeholder Impact
- Shareholders: Minimal impact; reflects standard director compensation.
Next Steps
- Vesting of 13,656 RSUs on June 11, 2027.
- Monthly vesting of 6,209 stock options over the 12 months following June 11, 2026.
Key Dates
| Date | Description |
|---|---|
| 01/08/2026 | Date Power of Attorney was executed by Michele M. Leonhart. |
| 06/10/2026 | Vesting date of 14,083 RSUs. |
| 06/11/2026 | Grant date for new RSUs and stock options. |
| 06/10/2036 | Expiration date for the new stock options. |
Keywords
908 Devices, MASS, Director Equity, Insider Trading, Form 4, Restricted Stock Units, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.